HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$37.02
Day range
$35.07 - $37.83
Year range
$33.27 - $47.80
Market cap
2.73B USD
Avg Volume
450.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.00M | 42.68% |
Net income | -65.68M | -46.81% |
Net profit margin | — | — |
Earnings per share | -0.84 | -31.25% |
EBITDA | -76.81M | -45.35% |
Effective tax rate | 5.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 626.90M | -1.75% |
Total assets | 798.14M | -17.27% |
Total liabilities | 43.24M | 17.24% |
Total equity | 754.90M | — |
Shares outstanding | 78.39M | — |
Price to book | 3.84 | — |
Return on assets | -23.71% | — |
Return on capital | -24.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -65.68M | -46.81% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1996
Headquarters
Website
Employees
316
